Kidney-Targeted Redox Scavenger Therapy Prevents Cisplatin-Induced Acute Kidney Injury

Cisplatin-induced acute kidney injury (CI-AKI) is a significant co-morbidity of chemotherapeutic regimens. While this condition is associated with substantially lower survival and increased economic burden, there is no pharmacological agent to effectively treat CI-AKI. The disease is hallmarked by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Ryan M., Shah, Janki, Mercer, Elizabeth, Tian, Helen S., Thompson, Vanessa, Cheung, Justin M., Dorso, Madeline, Kubala, Jaclyn M., Gudas, Lorraine J., de Stanchina, Elisa, Jaimes, Edgar A., Heller, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762298/
https://www.ncbi.nlm.nih.gov/pubmed/35046813
http://dx.doi.org/10.3389/fphar.2021.790913

Ejemplares similares

Ejemplares similares